BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Q, Deng Y, Cheng F, Kang J, Zhong S, Zhang D, Zeng W. Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis. Medicine (Baltimore) 2016;95:e5578. [PMID: 27977591 DOI: 10.1097/MD.0000000000005578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Sobhonslidsuk A, Numthavaj P, Wanichanuwat J, Sophonsritsuk A, Petraksa S, Pugasub A, Jittorntam P, Kongsomgan A, Roytrakul S, Phakdeekitcharoen B. Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B. Biomed Res Int. 2017;2017:4327385. [PMID: 29214169 DOI: 10.1155/2017/4327385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Feng J, Huang J, Li Z. Kushenin combined with adefovir dipivoxil affects the HBV-DNA load in serum, immune functions and liver functions of patients with chronic hepatitis B. Exp Ther Med 2017;14:5837-42. [PMID: 29285129 DOI: 10.3892/etm.2017.5266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Ma YH. Effect of adding on telbivudine or switching to telbivudine alone on therapeutic efficacy and renal function in chronic hepatitis B patients on adefovir dipivoxil monotherapy. Shijie Huaren Xiaohua Zazhi 2018; 26(14): 862-866 [DOI: 10.11569/wcjd.v26.i14.862] [Reference Citation Analysis]